Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone for Hemodynamics in Septic Shock
NCT05122884Phase 2Unknown
- Sponsor
- Mahidol University
- Start
- Dec 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milrinone in septic shock, sponsored by Mahidol University. Status: unknown.
02
Drugs
milrinone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT05122884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05122884.